Dr. Michael Blundell profile page

Mike Blundell graduated from the University of Edinburgh with a BSc (Hons). in Immunology. He then moved to University College London, where he joined the group of Prof. Adrian Thrasher and obtained his PhD. His thesis research was focused on the primary immunodeficiency Wiskott Aldrich Syndrome, and he contributed to over 50 peer-reviewed papers. He investigated novel activating mutations and developed lentiviral vectors for gene therapy treatments, which have now been successfully used in clinical trials. Mike left academia in 2015 to become a Product Manager for flow cytometry reagents at Bio-Rad.